Matthew Bejosa Frankel - Net Worth and Insider Trading

Matthew Bejosa Frankel Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Matthew Bejosa Frankel owns 1 companies in total, including Chemomab Therapeutics Ltd (CMMB) .

Click here to see the complete history of Matthew Bejosa Frankel’s form 4 insider trades.

Insider Ownership Summary of Matthew Bejosa Frankel

Ticker	Company	Transaction Date	Type of Owner
CMMB	Chemomab Therapeutics Ltd	2022-11-14	Chief Medical Officer

Matthew Bejosa Frankel Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Matthew Bejosa Frankel Ownership Network

Ownership Network List of Matthew Bejosa Frankel

No Data

Ownership Network Relation of Matthew Bejosa Frankel

Matthew Bejosa Frankel Owned Company Details

What does Chemomab Therapeutics Ltd do?

Who are the key executives at Chemomab Therapeutics Ltd?

Matthew Bejosa Frankel is the Chief Medical Officer of Chemomab Therapeutics Ltd. Other key executives at Chemomab Therapeutics Ltd include 10 percent owner Orbimed Israel Biofund Gp Limited Partnership , director & 10 percent owner & Chief Executive Officer George Adi Mor , and Executive VP & CFO & COO Donald Marvin .

Chemomab Therapeutics Ltd (CMMB) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Chemomab Therapeutics Ltd (CMMB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Chemomab Therapeutics Ltd (CMMB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Chemomab Therapeutics Ltd (CMMB)'s detailed insider trading history can be found in Insider Trading Tracker table.

Chemomab Therapeutics Ltd Insider Transactions

No Available Data

Matthew Bejosa Frankel Mailing Address

Above is the net worth, insider trading, and ownership report for Matthew Bejosa Frankel. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Matthew Bejosa Frankel's mailing address is: Princeton Nj 08540.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.